Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-06-07 @ 8:09 PM
Study NCT ID:
NCT03280667
Status:
UNKNOWN
Last Update Posted:
2023-03-29
First Post:
2017-09-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma
Sponsor:
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Organization: